CNBC's "Fast Money" Stocks Drop In Major Reversal… And Opportunities In A Red-Hot Biotech Sector 11/20/25
Nov 20, 2025
Mike Coe, a savvy trader known for his short-term strategies, and John Flavin, CEO of Portal Innovation, dive into market fluctuations and the booming biotech sector. They discuss why Nvidia's disappointing earnings sparked a market sell-off and how Walmart shone amidst the chaos. Flavin highlights the surge in biotech valuations driven by M&A activity, strong scientific advancements, and state funding, particularly in Texas, making it an exciting time for life science startups.
AI Snips
Chapters
Transcript
Episode notes
Broad Reversal After Nvidia Fade
- The market experienced a sharp intraday reversal after NVIDIA's post-earnings pop faded and buyers exited quickly.
- Carter Worth and others suggest this could signal more downside given weak internal breadth despite index highs.
Index Highs Mask Narrow Leadership
- Despite record index highs earlier in November, the average S&P 500 stock remained far below its 52-week high, exposing narrow leadership.
- Carter Worth warns that index strength masked broad weakness likely to produce further weakness.
Favor Execution Over Valuation For Retailers
- Walmart's strong quarter and guidance raise suggest investors should focus on execution over simple valuation comparisons.
- Bill Simon highlights Walmart's digital push and Nasdaq move as strategic moves to win a digital valuation premium.